Global Abalone Peptide Market Growth 2025-2031

Publication ID:

LPI07252526

Publication Date:

July 2, 2025

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Abalone Peptide market size is predicted to grow from US$ 104 million in 2025 to US$ 147 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
Abalone peptide is a small molecule peptide product extracted from abalone meat or abalone viscera and obtained by proteolysis technology. It is rich in various amino acids, minerals, peptides and collagen and other active ingredients. It has the characteristics of high protein and low fat. It has the effects of enhancing immunity, beautifying and nourishing the skin, protecting eyesight, improving sleep, promoting wound healing, preventing Alzheimer's disease, and delaying aging. It can be used in functional foods, beauty and skin care products, special medical and special dietary foods and other fields.
United States market for Abalone Peptide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Abalone Peptide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Abalone Peptide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Abalone Peptide players cover Real Elixir, Green Stone Swiss, Sanxi Group, Hailongyuan Bio-Tech, Blue-Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎balone Peptide Industry Forecast鈥� looks at past sales and reviews total world Abalone Peptide sales in 2024, providing a comprehensive analysis by region and market sector of projected Abalone Peptide sales for 2025 through 2031. With Abalone Peptide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Abalone Peptide industry.
This Insight Report provides a comprehensive analysis of the global Abalone Peptide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Abalone Peptide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Abalone Peptide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Abalone Peptide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Abalone Peptide.
This report presents a comprehensive overview, market shares, and growth opportunities of Abalone Peptide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Abalone Oligopeptide
Abalone Protein Peptide
Segmentation by Application:
Functional Food
Beauty and Skin Care Products
Special Medical Meal
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Real Elixir
Green Stone Swiss
Sanxi Group
Hailongyuan Bio-Tech
Blue-Peptides
Hainan Huayan Collagen Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Abalone Peptide market?
What factors are driving Abalone Peptide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Abalone Peptide market opportunities vary by end market size?
How does Abalone Peptide break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Abalone Peptide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Abalone Peptide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Abalone Peptide by Country/Region, 2020, 2024 & 2031
2.2 Abalone Peptide Segment by Type
2.2.1 Abalone Oligopeptide
2.2.2 Abalone Protein Peptide
2.3 Abalone Peptide Sales by Type
2.3.1 Global Abalone Peptide Sales Market Share by Type (2020-2025)
2.3.2 Global Abalone Peptide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Abalone Peptide Sale Price by Type (2020-2025)
2.4 Abalone Peptide Segment by Application
2.4.1 Functional Food
2.4.2 Beauty and Skin Care Products
2.4.3 Special Medical Meal
2.4.4 Others
2.5 Abalone Peptide Sales by Application
2.5.1 Global Abalone Peptide Sale Market Share by Application (2020-2025)
2.5.2 Global Abalone Peptide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Abalone Peptide Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Abalone Peptide Breakdown Data by Company
3.1.1 Global Abalone Peptide Annual Sales by Company (2020-2025)
3.1.2 Global Abalone Peptide Sales Market Share by Company (2020-2025)
3.2 Global Abalone Peptide Annual Revenue by Company (2020-2025)
3.2.1 Global Abalone Peptide Revenue by Company (2020-2025)
3.2.2 Global Abalone Peptide Revenue Market Share by Company (2020-2025)
3.3 Global Abalone Peptide Sale Price by Company
3.4 Key Manufacturers Abalone Peptide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Abalone Peptide Product Location Distribution
3.4.2 Players Abalone Peptide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Abalone Peptide by Geographic Region
4.1 World Historic Abalone Peptide Market Size by Geographic Region (2020-2025)
4.1.1 Global Abalone Peptide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Abalone Peptide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Abalone Peptide Market Size by Country/Region (2020-2025)
4.2.1 Global Abalone Peptide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Abalone Peptide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Abalone Peptide Sales Growth
4.4 APAC Abalone Peptide Sales Growth
4.5 Europe Abalone Peptide Sales Growth
4.6 Middle East & Africa Abalone Peptide Sales Growth
5 Americas
5.1 Americas Abalone Peptide Sales by Country
5.1.1 Americas Abalone Peptide Sales by Country (2020-2025)
5.1.2 Americas Abalone Peptide Revenue by Country (2020-2025)
5.2 Americas Abalone Peptide Sales by Type (2020-2025)
5.3 Americas Abalone Peptide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Abalone Peptide Sales by Region
6.1.1 APAC Abalone Peptide Sales by Region (2020-2025)
6.1.2 APAC Abalone Peptide Revenue by Region (2020-2025)
6.2 APAC Abalone Peptide Sales by Type (2020-2025)
6.3 APAC Abalone Peptide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Abalone Peptide by Country
7.1.1 Europe Abalone Peptide Sales by Country (2020-2025)
7.1.2 Europe Abalone Peptide Revenue by Country (2020-2025)
7.2 Europe Abalone Peptide Sales by Type (2020-2025)
7.3 Europe Abalone Peptide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Abalone Peptide by Country
8.1.1 Middle East & Africa Abalone Peptide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Abalone Peptide Revenue by Country (2020-2025)
8.2 Middle East & Africa Abalone Peptide Sales by Type (2020-2025)
8.3 Middle East & Africa Abalone Peptide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Abalone Peptide
10.3 Manufacturing Process Analysis of Abalone Peptide
10.4 Industry Chain Structure of Abalone Peptide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Abalone Peptide Distributors
11.3 Abalone Peptide Customer
12 World Forecast Review for Abalone Peptide by Geographic Region
12.1 Global Abalone Peptide Market Size Forecast by Region
12.1.1 Global Abalone Peptide Forecast by Region (2026-2031)
12.1.2 Global Abalone Peptide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Abalone Peptide Forecast by Type (2026-2031)
12.7 Global Abalone Peptide Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Real Elixir
13.1.1 Real Elixir Company Information
13.1.2 Real Elixir Abalone Peptide Product Portfolios and Specifications
13.1.3 Real Elixir Abalone Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Real Elixir Main Business Overview
13.1.5 Real Elixir Latest Developments
13.2 Green Stone Swiss
13.2.1 Green Stone Swiss Company Information
13.2.2 Green Stone Swiss Abalone Peptide Product Portfolios and Specifications
13.2.3 Green Stone Swiss Abalone Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Green Stone Swiss Main Business Overview
13.2.5 Green Stone Swiss Latest Developments
13.3 Sanxi Group
13.3.1 Sanxi Group Company Information
13.3.2 Sanxi Group Abalone Peptide Product Portfolios and Specifications
13.3.3 Sanxi Group Abalone Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanxi Group Main Business Overview
13.3.5 Sanxi Group Latest Developments
13.4 Hailongyuan Bio-Tech
13.4.1 Hailongyuan Bio-Tech Company Information
13.4.2 Hailongyuan Bio-Tech Abalone Peptide Product Portfolios and Specifications
13.4.3 Hailongyuan Bio-Tech Abalone Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hailongyuan Bio-Tech Main Business Overview
13.4.5 Hailongyuan Bio-Tech Latest Developments
13.5 Blue-Peptides
13.5.1 Blue-Peptides Company Information
13.5.2 Blue-Peptides Abalone Peptide Product Portfolios and Specifications
13.5.3 Blue-Peptides Abalone Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Blue-Peptides Main Business Overview
13.5.5 Blue-Peptides Latest Developments
13.6 Hainan Huayan Collagen Technology
13.6.1 Hainan Huayan Collagen Technology Company Information
13.6.2 Hainan Huayan Collagen Technology Abalone Peptide Product Portfolios and Specifications
13.6.3 Hainan Huayan Collagen Technology Abalone Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hainan Huayan Collagen Technology Main Business Overview
13.6.5 Hainan Huayan Collagen Technology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂